Ten years ago, people would have laughed at you for saying we would soon be walking around with mini-computers tethered to us. Now millions of people won’t step out the door without their beloved BlackBerry or iPhone. If you had put $10,000 into Research… Read More
Analyst Articles
China denied it for years. And it wasn’t until April of last year that the communist nation finally came clean. Finally, in the spring of 2010 — only after satellite images had been released of construction taking place — China officially told its Indian neighbor that it… Read More
Warren Buffett’s Favorite Auto Stock
When I went to the Berkshire Hathaway (NYSE: BRK-B) annual meeting in 2009, there was something I really wanted to do. No, it wasn’t a chat with Warren Buffett. That’s almost impossible at the yearly “Woodstock for Capitalists,” and only first-timers make the trek… Read More
Not many people have heard of the Defense Advanced Research Projects Agency, DARPA for short, much less know what it does. But this little-known government agency was created by the Department of Defense in the late 1950s to ensure the U.S. military’s technical superiority. Even more interesting to investors, it… Read More
A $40 Billion Flood of Cash is About to Hit This Sector
It’s no surprise when I started my Game-Changing Stocks service that my publisher and I picked the name we did. For me, this is what it’s all about — not market timing, value investing, vulture investing or swing trading; it’s about finding the next… Read More
The Quiet Revolution That’s Sent One Stock Up +49% Since July
You are taking part in a revolution. If you pay to drive through a toll booth, or you travel abroad, or in some cases use your credit card, you’re a willing participant. But this handful of actions is just a sliver of what’s to come. Read More
What I Learned From a Well-Known Stock Up +2,300%
Years ago, my dad and I were driving across his farm in his vintage Land Rover, which looks almost exactly like the one John Wayne used in the movie Hatari! The heavy-duty off-road tires were having a hard slog through the mud. Dad had cut across a… Read More
Huge Untapped Profits Are Waiting In The Chilean Desert
Look around the room you are in. I guarantee there’s at least a dozen devices powered by electricity, and of those, at least a few are powered by batteries. Batteries — or in more precise terms, energy storage devices — have remained pretty much unchanged… Read More
How to Profit From the Greatest Engineering Feat in History
Do you know what the National Academy of Engineering named as the world’s greatest engineering feat? It wasn’t the pyramids. It wasn’t Hoover Dam. It wasn’t the Burj Khalifa, the world’s tallest building at 2,717 feet, either. It was the United States’ electrical grid. Read More
The Best Growth Stock to Hold Forever
If I had to pick a stock that offered indefinite growth potential, I’d bet big on a fungus. My choice for “The Best Growth Stock to Hold Forever” is a biotech pioneer called Dyadic International (OTC: DYAI). Most people have never heard of this little Florida-based gem, but in the coming years, I think it will rise to prominence as one of the nation’s leading bio-industrial concern, supplying several key sectors of the economy with vital tools to carry out a host of manufacturing tasks. This maker of specialty enzymes has this lock… Read More
If I had to pick a stock that offered indefinite growth potential, I’d bet big on a fungus. My choice for “The Best Growth Stock to Hold Forever” is a biotech pioneer called Dyadic International (OTC: DYAI). Most people have never heard of this little Florida-based gem, but in the coming years, I think it will rise to prominence as one of the nation’s leading bio-industrial concern, supplying several key sectors of the economy with vital tools to carry out a host of manufacturing tasks. This maker of specialty enzymes has this lock on the future because it owns a special fungus called C-1. In the hands of genetic engineers — Dyadic CEO Mark Emalfarb calls them “gene jockeys,” C-1 can be programmed to generate vast quantities of enzymes. One of the key areas that will be effected is the pharmaceutical industry. Many of today’s leading drugs are the result not simply of a certain chemical formula — made by mixing those chemicals together and stamping out pills — but of certain biological processes. That is, the medicine you take, one way or another, is the result of a process… Read More